[Advances in CRISPR-Cas9 genome editing for the treatment of muscular dystrophies].
Zhonghua er ke za zhi = Chinese journal of pediatrics, 63(7): 808-811 PMID 40518166 DOI 10.3760/cma.j.cn112140-20250421-00356
Abstract
This article has no abstract in PubMed.